Alliance A031201: A phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic castration resistant prostate cancer (mCRPC)
- Citation:
- J Clin Oncol vol 37 (suppl) abstr 5008
- Meeting Instance:
- ASCO 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 3845
- Pharmas:
- Astellas
- Grants:
- U10CA180821, U10CA180882, U24CA196171, U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Michael J. Morris Glenn Heller Alan Bryce Andrew Armstrong Himisha Beltran Olwen Hahn Eric C. McGary Paul Mehan Bruce Roth Han Xiao Colleen Watt David Hillman Mary Ellen Taplin Charles J. Ryan Susan Halabi Eric Small
- Networks:
- CA136, HEARTLAND, KAISER, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC010, LAPS-NY016, MN022
- Study
- Alliance-A031201
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: